Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fincon Reply is a business and IT consultancy specializing in digital transformation for the financial services sector—primarily serving banks, savings institutions (Sparkassen), cooperative finance groups, insurers, and their suppliers. The company offers expertise in core banking systems integration, regulatory compliance solutions, cloudification projects, AI/data management initiatives, process optimization (notably via participation in the BiPRO Hub project), migrations/testing services—and more. It was acquired by Italian tech group Reply S.p.A. in mid‑2022 but continues to operate under its own brand within the group structure.
Fincon Reply does not operate within life sciences/biotech/pharma/healthcare fields—it focuses exclusively on financial services technology consulting[1][2][3].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fincon Reply.